Skip to content
healthcare.dev

Pyridostigmine Bromide

NDC 0115-2134, PYRIDOSTIGMINE BROMIDE, tablet, from Amneal Pharmaceuticals of New York LLC.

Product NDC
0115-2134
Status
Listed
Labeler
Amneal Pharmaceuticals of New York LLC
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA040502
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0115-2134 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • PYRIDOSTIGMINE BROMIDE30 mg/1

Pharmacologic classes

Cholinesterase Inhibitor [EPC]; Cholinesterase Inhibitors [MoA]

Package NDCNDC-11Package
0115-2134-010011521340121 TABLET in 1 BOTTLE (0115-2134-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/91ca7bcf-d2cc-4cb3-bfbe-c294fd707524

Use it

Look up 0115-2134 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0115-2134 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0115-2134. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.